Pharmena S.A.
PHR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | -97.3% | 3,190% | -98% | – |
| Gross Profit | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Margin | 73.9% | 59.4% | 3,456.5% | 51.5% |
| EBITDA | -PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -1,261.9% | 361.4% | -43.1% | -23.1% |
| Net Income | -PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -470.9% | 294.2% | -525.1% | -30.2% |
| EPS Diluted | -0.11 | 2.6 | -0.14 | -0.41 |
| % Growth | -104.2% | 1,957.1% | 65.9% | – |
| Operating Cash Flow | -PLN 0 | PLN 0 | PLN 0 | -PLN 0 |
| Capital Expenditures | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 0 | PLN 0 | PLN 0 | -PLN 0 |